Skip to main content

Cerebral vasoreactivity is not impaired in patients with severe sepsis

Introduction

In a previous report it was observed that acetazolamide-induced cerebrovascular reactivity is impaired in patients with sepsis-associated encephalopathy without organ dysfunction [1]. The aim of the present work was to assess whether patients suffering from severe sepsis also have these impaired cerebrovascular responses.

Methods

Patients fulfilling the criteria of clinical sepsis and showing at least two organ dysfunctions other than the brain were included (n = 14). Nonseptic persons without previous diseases affecting cerebral vasoreactivity served as controls (n = 20). Transcranial Doppler blood flow velocities were measured at rest and at 5, 10, 15 and 20 minutes after intravenous administration of 15 mg/kg BW acetazolamide. The time course of the acetazolamide effect on cerebral blood flow velocity (cerebrovascular reactivity) and the maximal vasodilatory effect of acetazolemide (cerebrovascular reserve capacity (CRC)) were compared among the groups.

Results

Mean blood flow velocity in the middle cerebral artery was lower (41.7 ± 13.3 cm/second) in septic patients at rest than in controls (58.2 ± 12.0 cm/second, P < 0.01). Pulsatility indices were higher among septic patients at rest (1.56 ± 0.79) than in controls (0.85 ± 0.20, P < 0.01). Assessment of the time course of the vasomotor reaction showed that patients with sepsis reacted in similar fashion and extent to the vasodilatory stimulus than did control persons. When assessing the maximal vasodilatory ability of the cerebral arterioles to acetazolamide during vasomotor testing, we found that patients with sepsis reacted to a similar extent to the drug than did control subjects (CRC controls:46.2 ± 15.9%, CRC SAE: 63.2 ± 28.4%).

Conclusions

Cerebral vasoreactivity to acetazolemide is not impaired in patients with severe sepsis. Our data suggest that the reaction of the cerebral arterioles to vasoactive stimuli changes along with the severity of the septic process.

References

  1. 1.

    Szatmari , et al.: Crit Care. 2010, 14: R50. 10.1186/cc8939

    PubMed Central  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to S Szatmári.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Szatmári, S., Fülep, Z., Sárkány, P. et al. Cerebral vasoreactivity is not impaired in patients with severe sepsis. Crit Care 15, P319 (2011). https://doi.org/10.1186/cc9739

Download citation

Keywords

  • Severe Sepsis
  • Septic Patient
  • Blood Flow Velocity
  • Acetazolamide
  • Pulsatility Index